New tech aims to simplify diabetes management

NCT ID NCT05785832

Completed Disease control Sponsor: Tandem Diabetes Care, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a smart insulin system called Control-IQ+ in 319 adults with type 2 diabetes who use insulin. The goal was to see if the technology helps control blood sugar better than standard care. Participants used the system for a period, and researchers measured changes in blood sugar levels and safety.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 2 DIABETES TREATED WITH INSULIN

Contacts and locations

Show contact details

Locations

Baltimore VA Medical Center

Baltimore, Maryland, 21201, United States
Boston Medical Center Corporation

Boston, Massachusetts, 02118, United States
Diabetes & Endocrine Treatment Specialists

Sandy City, Utah, 84093, United States
Emory University School of Medicine

Atlanta, Georgia, 30303, United States
Henry Ford Health System

Detroit, Michigan, 48202, United States
Hoag Memorial Hospital Presbyterian

Newport Beach, California, 92663, United States
Icahn School of Medicine at Mt. Sinai

New York, New York, 10029, United States
Lawson Health Research Institute

London, Ontario, N6A 4V2, Canada
Mayo Clinic

Rochester, Minnesota, 55905, United States
McGill University

Montreal, Quebec, H4A 3J1, Canada
Northwestern University

Chicago, Illinois, 60611, United States
Oregon Health & Science University

Portland, Oregon, 97239, United States
Rainier Clinical Research Center

Renton, Washington, 98057, United States
Rocky Mountain Clinical Research

Idaho Falls, Idaho, 83404, United States
SUNY Upstate Medical University

Syracuse, New York, 13210, United States
Texas Diabetes and Endocrinology, P.A.

Austin, Texas, 78731, United States
UHH Cleveland Medical Center

Cleveland, Ohio, 44106, United States
University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States
University of Texas Southwestern

Dallas, Texas, 75013, United States
University of Virginia

Charlottesville, Virginia, 22903, United States
University of Washington

Seattle, Washington, 98109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.